← Product Code [GWQ](/submissions/NE/subpart-b%E2%80%94neurological-diagnostic-devices/GWQ) · K033978 # ADAM (K033978) _Astro-Med, Inc. · GWQ · Feb 18, 2004 · Neurology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/NE/subpart-b%E2%80%94neurological-diagnostic-devices/GWQ/K033978 ## Device Facts - **Applicant:** Astro-Med, Inc. - **Product Code:** [GWQ](/submissions/NE/subpart-b%E2%80%94neurological-diagnostic-devices/GWQ.md) - **Decision Date:** Feb 18, 2004 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 882.1400 - **Device Class:** Class 2 - **Review Panel:** Neurology ## Indications for Use The ADAM amplifier system is intended for recording routine EEG and EEG associated with long term monitoring for epilepsy. This device is intended to be used only by physicians, technicians, or other medical professionals that are trained in electroencephalography. ## Device Story ADAM is an EEG amplifier system used for routine EEG and long-term epilepsy monitoring. It captures electrical brain activity signals via electrodes; amplifies and processes these signals for display and recording. Operated by trained physicians or technicians in clinical settings. Output allows clinicians to visualize and interpret EEG waveforms to support epilepsy diagnosis and management. Benefits include reliable signal acquisition for neurological assessment. ## Clinical Evidence No clinical data provided; bench testing only. ## Technological Characteristics EEG amplifier system; Class II device; 21 CFR 882.1400; product code GWQ. Designed for signal acquisition and amplification for electroencephalography. ## Regulatory Identification An electroencephalograph is a device used to measure and record the electrical activity of the patient's brain obtained by placing two or more electrodes on the head. ## Predicate Devices - Telefactor H2O ([K992291](/device/K992291.md)) - Telefactor H2O ([K974587](/device/K974587.md)) - Grass - Telefactor AS-40 Amplifier System ([K021807](/device/K021807.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ FEB 1 8 2004 Image /page/0/Picture/2 description: The image shows a handwritten alphanumeric string. The string starts with the letter 'K', followed by the numbers '033978'. The handwriting is somewhat cursive, with the numbers being connected to each other. ## 510 (K) Summary 2 This summary is submitted in accordance with the requirements of 807.92. This summary was prepared on Dec 11, 2003 | Submitted By: | Grass-Telefactor Product Group
Astro-Med, Inc.
600 East Greenwich Ave
West Warwick, RI 02893
Tel: (401) 828-4000
Fax: (401) 822-2480 | |---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------| | Contact Person: | Michael J. Sullivan
VP Engineering
Tel: 401-828-4000 x212
Email: msullivan@astromed.com | | Proprietary Name : | ADAM | | Common Name: | EEG Amplifier System | | Product Category: | Electroencephalograph | | Regulation number: | 882.1400 | | Medical Speciality: | NE | | Product Code: | GWQ | | Product Class: | Class II Device | This device claims substantial equivalence to the following: Telefactor H2O: 510(k) numbers K992291 and K974587 Grass - Telefactor AS-40 Amplifier System 510(k) number K021807 Intended Use: The ADAM amplifier system is intended for recording routine EEG and EEG associated with long term monitoring for epilepsy. This device is intended to be used only by physicians, technicians, or other medical professionals that are trained in electroencephalography. {1}------------------------------------------------ Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 FEB 1 8 2004 Mr. Michael J. Sullivan Vice President of Engineering Grass-Telefactor Product Group Astro-Med, Inc. 600 East Greenwich Avenue West Warwick, Rhode Island 02893 Re: K033978 Trade/Device Name: Grass-Telefactor ADAM Regulation Number: 21 CFR 882.1400 Regulation Name: Electroencephalograph Regulatory Class: II Product Code: GWQ Dated: December 19, 2003 Received: January 5, 2004 Dear Mr. Sullivan: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a promarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {2}------------------------------------------------ Page 2 - Mr. Michael J. Sullivan This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours. Mark N. Millians Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ ## Indications for Use 510(k) Number (if known): 《 033978 Device Name: Grass-Telefactor ADAM Indications For Use: : The ADAM amplifier system is intended for recording routine EEG and EEG associated with long term monitoring for epilepsy. This device is intended to be used only by physicians, technicians, or other medical professionals that are trained in electroencephalography. | Prescription Use
(Part 21 CFR 801 Subpart D) |
X
| |-------------------------------------------------|------------------------------------------------| | | AND/OR | | | Over-The-Counter Use
(21 CFR 807 Subpart C) | (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) *for* Mark N Millersen (Division Sign-Off) Division of General, Restorative, and Neurological Devices | 510(k) Number | K033978 | |---------------|---------------------------------------------------------| |---------------|---------------------------------------------------------| 5 --- **Source:** [https://fda.innolitics.com/submissions/NE/subpart-b%E2%80%94neurological-diagnostic-devices/GWQ/K033978](https://fda.innolitics.com/submissions/NE/subpart-b%E2%80%94neurological-diagnostic-devices/GWQ/K033978) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com